Preclinical study finds insomnia drug blocks oxycodone relapse
The insomnia drug suvorexant (Belsomra) might be an effective treatment for opioid use disorder, according to a preclinical study from Scripps Research.
Apr 27, 2023
0
36
The insomnia drug suvorexant (Belsomra) might be an effective treatment for opioid use disorder, according to a preclinical study from Scripps Research.
Apr 27, 2023
0
36
New research out of the University of Cincinnati examines the association between genetics and the presence of opioid use disorder (OUD). The study identified six single nucleotide polymorphisms (SNPs) or genetic variants ...
Apr 27, 2023
0
1
People with cerebral palsy are more likely to be prescribed opioids to manage pain, making them vulnerable to the ongoing opioid crisis in the United States, according to a new study.
Apr 25, 2023
0
16
The human body naturally produces opioid-like substances, such as endorphins, that block the perception of pain and increase the feeling of well-being. Similarly, opioid drugs, including morphine or fentanyl, are widely used ...
Apr 19, 2023
0
77
A new study sheds light on an understudied aspect of today's opioid crisis: What happens to the cardiovascular health of babies exposed to opioids in the womb. The outcomes of the study suggest that children born to mothers ...
Apr 19, 2023
0
7
A new therapeutic designed by Scripps Research chemists can alter the molecular structure of the potent opioid carfentanil, inactivating the opioid and reversing a carfentanil overdose. The compound, which is described in ...
Apr 17, 2023
0
3
New research from Boston Medical Center concluded that offering medications to treat opioid addiction in jails and prisons leads to a decrease in overdose deaths. Published in JAMA Network Open, the study also found that ...
Apr 14, 2023
0
66
Anorexia nervosa (AN) is the deadliest psychiatric illness aside from opioid use disorder, with scarce effective treatment options. A new study by Yale researchers reveals a potential new therapeutic for the disorder, as ...
Apr 13, 2023
0
15
Approximately 7 million adults in the U.S. are living with opioid use disorder (OUD). Yet a new Northwestern Medicine study that measured residential treatment use among Medicaid enrollees across nine states found only 7% ...
Apr 13, 2023
0
2
The U.S. has named a veterinary tranquilizer as an "emerging threat" when it's mixed with the powerful opioid fentanyl, clearing the way for more efforts to stop the spread of xylazine.
Apr 12, 2023
0
7